Anti-Ageing Drugs Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Size, Share & Trends, Drivers, Restraints, Opportunities, Manufacturer, Applications, And Segments

  • AMR-1064336
  • May 2021
  • Pharmaceuticals
  • 123 Pages
The global Anti-Ageing Drugs market research report provides complete study and detail analysis of the market. This study includes forecast analysis of the market which is based on global and regional level, whereas the research reports the provides forecast data from 2020-2028 and historic of 2018 and 2019. All the values are based on revenue USD Million. Moreover, the market research report describes various segments of the Anti-Ageing Drugs market based on its types, applications and end-use industry. The applications of the market are explained in different industry verticals with reference to major countries across the globe. Along with this, the research report also covers all the major players that are operating in the global Anti-Ageing Drugs market. These major players of the market are further studied and analyzed based on various parameters, such as annual market revenue, annual sales of the company, marketing strategy, historic growth and shipment volumes. Based on all the company’s insights, the market research analyst also suggests business strategy and marketing plans for improving the market position of existing participants of Anti-Ageing Drugs market.
 
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2020
Forecast Period Covered 2020 – 2028
Units for value Revenue in USD million and CAGR from 2020 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Companies Covered Galderma, Sanofi, Allergan, Daewoong Pharmaceuticals, Revitacare, Merz Pharma, Nu Skin, BIOTIME, INC., Elysium Health Inc., La Roche-Posay, DermaFix, L\'ORÉAL
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa

COVID-19 Impact Analysis
The analysis of covid-19 is based on the impact of the current pandemic situation on market scenarios. This includes impact of covid-19 outbreak on overall revenue, market segments as well as regional market. The report also puts light on detailed impact analysis by taking into consideration all the government policies imposed during the pandemic situation, temporary shutdown of manufacturing units, current state of supply chain and distributors, and its future impacts on the growth of overall market. The market study will assist user to understand the global demand and impose strategic business plans to compete with the peers.

Apart from this, the market research report also covers drivers and restraints for the global Anti-Ageing Drugs market and their impact on the demand and supply during the forecast period. Along with this, the research report also provides Anti-Ageing Drugs market trends and opportunities that are based on regional and global level. Furthermore, the market research report also provides the major distributors and manufacturers that are operating in all the key region across the world. The researched data provided in the report is widely used by various industry players to strengthen their distribution channel and improve the geographical reach. In addition, the report also covers all the major players of the global Anti-Ageing Drugs market and its key offerings and solutions. The report also provides recent mergers and acquisitions of these key players.

The data which is provided in the market research report is analyzed and evaluated with the help of various marketing tools, such as SWOT analysis, Poster’s Five Force analysis, PESTEL analysis, value chain analysis, player positioning analysis and market share analysis. Therefore, this analysis tools helps the analyst to evaluate the Anti-Ageing Drugs market based on various parameters such as capital investments, impact of consumer’s preferences, economies of scale, manufacturing rights and patents, existing distribution channels, switching costs, government regulations and brand loyalty.

Major Key Players for Global Anti-Ageing Drugs Market:
The Anti-Ageing Drugs market research report offers the company profile of major key players including progress trends, competitive landscape breakdown, and key in regions development status. Galderma, Sanofi, Allergan, Daewoong Pharmaceuticals, Revitacare, Merz Pharma, Nu Skin, BIOTIME, INC., Elysium Health Inc., La Roche-Posay, DermaFix, L\'ORÉAL

Anti-Ageing Drugs Market Segment Analysis:
By Type
Injectable
Oral
Topical
Drug Class
Antioxidants and enzymes
Serums and supplements
Stem cells
Applications
Skin
Hair
Muscles
Age-related disorders
Others

Geographic Coverage for Anti-Ageing Drugs Market:
The market research report on global Anti-Ageing Drugs market offers complete analysis across various regions across the world. The Anti-Ageing Drugs market is distributed into various regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa. The global leading market share as per the region is evaluated after considering Anti-Ageing Drugs market revenue, sales, shares, recent developments, innovations and growth rates. This section of regional analysis provides widespread evaluation of the industry from various countries and regions.

North America Anti-Ageing Drugs Market Value and Forecast
  • US
  • Canada
Europe Anti-Ageing Drugs Market Value and Forecast
  • UK
  • Germany
  • France
  •  Rest of Europe
Asia Pacific Anti-Ageing Drugs Market Value and Forecast
  • China
  • Japan
  • India
  • Rest of Asia Pacific
Latin America Anti-Ageing Drugs Market Value and Forecast
  • Mexico
  • Brazil
  • Rest of Latin America
Middle East and Africa Anti-Ageing Drugs Market Value and Forecast
  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa


Key highlights of the Anti-Ageing Drugs market report:
  • The report provides key trends of the global Anti-Ageing Drugs market
  • The report also covers consumer preferences and current industry growth
  • Key products or solutions offered by the main players in the Anti-Ageing Drugs industry
  • The report covers all the recent developments of the Anti-Ageing Drugs market and helps to provide current industry updates
  • The report covers a detailed look over the global Anti-Ageing Drugs Industry and provides with significant actionable insights
  • The Anti-Ageing Drugs market estimation from 2020-2028 and historical data for 2018 and 2019
  • The market study also provides data on changing market dynamics, market intelligence, current and future market trends
  • The report also analyses the microeconomic and macroeconomic factors that are affecting the global Anti-Ageing Drugs market
  • In-depth analysis of the market’s competitive landscape and detailed information about the vendors
  • The report also offers key market drivers, restrains, trends and opportunities with present and future impact on the market
  • Detailed information about the major players or manufacturers of the global Anti-Ageing Drugs market
  • Comprehensive analysis of the Anti-Ageing Drugs market segments based on its types, applications and end-use industry
Key Analytical Areas:
The report aims to offer a complete solution to various businesses operating in the Anti-Ageing Drugs market in making strategic decisions based on credible information and actionable insights. Thereby, the report covers various aspects of your requirements such as industry overview, market dynamics, regional analysis and competitive landscape. The report aims to provide insights to businesses in the Anti-Ageing Drugs market for numerous purposes such as:

     1. Strategic Decision Making:
With the help of this report, key decision makers can quickly analyze and identify growth opportunities in terms of numerous segments across various geographical regions. Thereby, this report enables organizations to identify and make strategic investments in specific market segments in order to gain maximum return on investment.

      2.  Actionable Insights:
The report offers a deep dive into how companies are leveraging market conditions to make the most in the Anti-Ageing Drugs market. Thereby, the report offers numerous actionable insights into the best practices and key success factors relevant in the Anti-Ageing Drugs market. Using the insights included in the report, businesses can make quick decisions to achieve success in business operations.

      3. Competitive Snapshot:
In addition, to detailed information on the companies operating in the Anti-Ageing Drugs market, the report also includes a competitive snapshot of all the companies covered in the report. Thereby, this offers a visual representation of how all the companies stand comparatively based on their competencies, geographic presence, market hold, years of operations, employee and financial strength, among others.

Manufacturers and Segments

  • Galderma
  • Sanofi
  • Allergan
  • Daewoong Pharmaceuticals
  • Revitacare
  • Merz Pharma
  • Nu Skin
  • BIOTIME, INC.
  • Elysium Health Inc.
  • La Roche-Posay
  • DermaFix
  • L'ORÉAL
  • Injectable
  • Oral
  • Topical
  • Skin
  • Hair
  • Muscles
  • Age-related disorders
  • Others

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summarysegment Form
     2.1. Global Anti-Ageing Drugs Market Snapshot
          2.1.1. Global Anti-Ageing Drugs Market By Type,2019
               2.1.1.1.Injectable
               2.1.1.2.Oral
               2.1.1.3.Topical
          2.1.2. Global Anti-Ageing Drugs Market By Applications,2019
               2.1.2.1.Skin
               2.1.2.2.Hair
               2.1.2.3.Muscles
               2.1.2.4.Age-related disorders
               2.1.2.5.Others
          2.1.3. Global Anti-Ageing Drugs Market By End-use,2019
          2.1.4. Global Anti-Ageing Drugs Market By Geography,2019

3. Global Anti-Ageing Drugs Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Anti-Ageing Drugs Market Size (US$), By Type, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Type, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Type, 2020
     4.2. Global Anti-Ageing Drugs Market Size (US$), By Type, 2018 – 2028

5. Global Anti-Ageing Drugs Market Size (US$), By Applications, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By Applications, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By Applications, 2020
     5.2. Global Anti-Ageing Drugs Market Size (US$), By Applications, 2018 – 2028

6. Global Anti-Ageing Drugs Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Anti-Ageing Drugs Market Size (US$), By End-use, 2018 – 2028

7. Global Anti-Ageing Drugs Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Anti-Ageing Drugs Market Analysis, 2018 – 2028 
          7.2.1. North America Anti-Ageing Drugs Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Anti-Ageing Drugs Market Size (US$), By Type, 2018 – 2028
          7.2.3. North America Anti-Ageing Drugs Market Size (US$), By Applications, 2018 – 2028
          7.2.4. North America Anti-Ageing Drugs Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Anti-Ageing Drugs Market Analysis, 2018 – 2028 
          7.3.1.  Europe Anti-Ageing Drugs Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Anti-Ageing Drugs Market Size (US$), By Type, 2018 – 2028
          7.3.3. Europe Anti-Ageing Drugs Market Size (US$), By Applications, 2018 – 2028
          7.3.4. Europe Anti-Ageing Drugs Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Anti-Ageing Drugs Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Anti-Ageing Drugs Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Anti-Ageing Drugs Market Size (US$), By Type, 2018 – 2028
          7.4.3. Asia Pacific Anti-Ageing Drugs Market Size (US$), By Applications, 2018 – 2028
          7.4.4. Asia Pacific Anti-Ageing Drugs Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Anti-Ageing Drugs Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Anti-Ageing Drugs Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Anti-Ageing Drugs Market Size (US$), By Type, 2018 – 2028
          7.5.3. Latin America Anti-Ageing Drugs Market Size (US$), By Applications, 2018 – 2028
          7.5.4. Latin America Anti-Ageing Drugs Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Anti-Ageing Drugs Market Analysis, 2018 – 2028 
          7.6.1.  MEA Anti-Ageing Drugs Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Anti-Ageing Drugs Market Size (US$), By Type, 2018 – 2028
          7.6.3. MEA Anti-Ageing Drugs Market Size (US$), By Applications, 2018 – 2028
          7.6.4. MEA Anti-Ageing Drugs Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Anti-Ageing Drugs Providers
        8.4.1 Galderma
                8.4.1.1 Business Description
                8.4.1.2 Galderma Geographic Operations
                8.4.1.3 Galderma Financial Information
                8.4.1.4 Galderma Product Positions/Portfolio
                8.4.1.5 Galderma Key Developments
        8.4.2 Sanofi
                8.4.2.1 Business Description
                8.4.2.2 Sanofi Geographic Operations
                8.4.2.3 Sanofi Financial Information
                8.4.2.4 Sanofi Product Positions/Portfolio
                8.4.2.5 Sanofi Key Developments
        8.4.3 Allergan
                8.4.3.1 Business Description
                8.4.3.2 Allergan Geographic Operations
                8.4.3.3 Allergan Financial Information
                8.4.3.4 Allergan Product Positions/Portfolio
                8.4.3.5 Allergan Key Developments
        8.4.4 Daewoong Pharmaceuticals
                8.4.4.1 Business Description
                8.4.4.2 Daewoong Pharmaceuticals Geographic Operations
                8.4.4.3 Daewoong Pharmaceuticals Financial Information
                8.4.4.4 Daewoong Pharmaceuticals Product Positions/Portfolio
                8.4.4.5 Daewoong Pharmaceuticals Key Developments
        8.4.5 Revitacare
                8.4.5.1 Business Description
                8.4.5.2 Revitacare Geographic Operations
                8.4.5.3 Revitacare Financial Information
                8.4.5.4 Revitacare Product Positions/Portfolio
                8.4.5.5 Revitacare Key Developments
        8.4.6 Merz Pharma
                8.4.6.1 Business Description
                8.4.6.2 Merz Pharma Geographic Operations
                8.4.6.3 Merz Pharma Financial Information
                8.4.6.4 Merz Pharma Product Positions/Portfolio
                8.4.6.5 Merz Pharma Key Developments
        8.4.7 Nu Skin
                8.4.7.1 Business Description
                8.4.7.2 Nu Skin Geographic Operations
                8.4.7.3 Nu Skin Financial Information
                8.4.7.4 Nu Skin Product Positions/Portfolio
                8.4.7.5 Nu Skin Key Developments
        8.4.8 BIOTIME, INC.
                8.4.8.1 Business Description
                8.4.8.2 BIOTIME, INC. Geographic Operations
                8.4.8.3 BIOTIME, INC. Financial Information
                8.4.8.4 BIOTIME, INC. Product Positions/Portfolio
                8.4.8.5 BIOTIME, INC. Key Developments
        8.4.9 Elysium Health Inc.
                8.4.9.1 Business Description
                8.4.9.2 Elysium Health Inc. Geographic Operations
                8.4.9.3 Elysium Health Inc. Financial Information
                8.4.9.4 Elysium Health Inc. Product Positions/Portfolio
                8.4.9.5 Elysium Health Inc. Key Developments
        8.4.10 La Roche-Posay
                8.4.10.1 Business Description
                8.4.10.2 La Roche-Posay Geographic Operations
                8.4.10.3 La Roche-Posay Financial Information
                8.4.10.4 La Roche-Posay Product Positions/Portfolio
                8.4.10.5 La Roche-Posay Key Developments
        8.4.11 DermaFix
                8.4.11.1 Business Description
                8.4.11.2 DermaFix Geographic Operations
                8.4.11.3 DermaFix Financial Information
                8.4.11.4 DermaFix Product Positions/Portfolio
                8.4.11.5 DermaFix Key Developments
        8.4.12 L'ORÉAL
                8.4.12.1 Business Description
                8.4.12.2 L'ORÉAL Geographic Operations
                8.4.12.3 L'ORÉAL Financial Information
                8.4.12.4 L'ORÉAL Product Positions/Portfolio
                8.4.12.5 L'ORÉAL Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Anti-Ageing Drugs Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Anti-Ageing Drugs Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Anti-Ageing Drugs Market Revenue, By Applications, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Anti-Ageing Drugs Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Anti-Ageing Drugs Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Anti-Ageing Drugs Market Revenue, By Applications, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Anti-Ageing Drugs Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Anti-Ageing Drugs Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Anti-Ageing Drugs Market Revenue, By Applications, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Anti-Ageing Drugs Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Anti-Ageing Drugs Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Anti-Ageing Drugs Market Revenue, By Applications, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Anti-Ageing Drugs Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Anti-Ageing Drugs Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Anti-Ageing Drugs Market Revenue, By Applications, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Anti-Ageing Drugs Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Anti-Ageing Drugs: Market Segmentation 
FIG. 2 Global Anti-Ageing Drugs Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Anti-Ageing Drugs Market, By Type, 2019 (US$ Mn) 
FIG. 5 Global Anti-Ageing Drugs Market, By Applications, 2019 (US$ Mn) 
FIG. 6 Global Anti-Ageing Drugs Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Anti-Ageing Drugs Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Anti-Ageing Drugs Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Anti-Ageing Drugs Providers, 2019
FIG. 11 Global Anti-Ageing Drugs Market Revenue Contribution, By Type, 2019 & 2028 (Value %) 
FIG. 12 Global Anti-Ageing Drugs Market Revenue Contribution, By Applications, 2019 & 2028 (Value %) 
FIG. 13 Global Anti-Ageing Drugs Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Anti-Ageing Drugs Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Anti-Ageing Drugs Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Anti-Ageing Drugs Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Anti-Ageing Drugs Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Anti-Ageing Drugs Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Anti-Ageing Drugs market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global Anti-Ageing Drugs Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America Anti-Ageing Drugs Market Value, By Segment1, 2018 – 2028
TABLE  North America Anti-Ageing Drugs Market Value, By Segment2, 2018 – 2028
TABLE  North America Anti-Ageing Drugs Market Value, By Country, 2018 – 2028
TABLE  Europe Anti-Ageing Drugs Market Value, By Segment1, 2018 – 2028
TABLE  Europe Anti-Ageing Drugs Market Value, By Segment2, 2018 – 2028
TABLE  Europe Anti-Ageing Drugs Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific Anti-Ageing Drugs Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific Anti-Ageing Drugs Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific Anti-Ageing Drugs Market Value, By Country, 2018 – 2028
TABLE  Latin America Anti-Ageing Drugs Market Value, By Segment1, 2018 – 2028
TABLE  Latin America Anti-Ageing Drugs Market Value, By Segment2, 2018 – 2028
TABLE  Latin America Anti-Ageing Drugs Market Value, By Country, 2018 – 2028
TABLE  MEA Anti-Ageing Drugs Market Value, By Segment1, 2018 – 2028
TABLE  MEA Anti-Ageing Drugs Market Value, By Segment2, 2018 – 2028
TABLE  MEA Anti-Ageing Drugs Market Value, By Country, 2018 – 2028
TABLE  Galderma: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Sanofi: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Allergan: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Daewoong Pharmaceuticals: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Revitacare: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Merz Pharma: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Nu Skin: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  BIOTIME, INC.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Elysium Health Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  La Roche-Posay: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  DermaFix: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  L'ORÉAL: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global Anti-Ageing Drugs Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global Anti-Ageing Drugs Market, By Segment1, 2019 (US$ Mn)
FIG.  Global Anti-Ageing Drugs Market, By Segment2, 2019 (US$ Mn)
FIG.  Global Anti-Ageing Drugs Market, By Geography, 2019 (US$ Mn)
FIG.  Global Anti-Ageing Drugs Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key Anti-Ageing Drugs Providers, 2016
FIG.  Global Anti-Ageing Drugs Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global Oral Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Topical Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Anti-Ageing Drugs Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global Hair Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Muscles Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Age-related disorders Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Others Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. Anti-Ageing Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada Anti-Ageing Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK Anti-Ageing Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany Anti-Ageing Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  France Anti-Ageing Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe Anti-Ageing Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  China Anti-Ageing Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan Anti-Ageing Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  India Anti-Ageing Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific Anti-Ageing Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico Anti-Ageing Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil Anti-Ageing Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America Anti-Ageing Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries Anti-Ageing Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa Anti-Ageing Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA Anti-Ageing Drugs Market Value, 2018 – 2028, (US$ Mn)